Dual-Target Nanoparticles Reprogram Macrophages and Improve Survival in Experimental Sepsis in ssalimpour

Salimpour Website |Researchers developed glutathione-responsive EONPs that co-deliver STING and DHODH inhibitors to reprogram macrophage inflammatory metabolism in experimental sepsis. In mouse models, the treatment reduced inflammation and organ injury, improved short-term survival,

AZO Nano

Dual-Target Nanoparticles Reprogram Macrophages and Improve Survival in Experimental Sepsis

Dual-Target Nanoparticles Reprogram Macrophages and Improve Survival in Experimental Sepsis

Researchers developed glutathione-responsive EONPs that co-deliver STING and DHODH inhibitors to reprogram macrophage inflammatory metabolism in experimental sepsis. In mouse models, the treatment reduced inflammation and organ injury, improved short-term survival, and altered gut microbial metabolism, with 5-HIAA contributing to the immune response.